Selected article for: "peptidase degradation stability and variable region"

Author: Carabineiro, Sónia Alexandra Correia
Title: Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines †
  • Document date: 2017_5_22
  • ID: 0nz0qioh_37
    Snippet: It was shown that conjugation to negatively charged gold glyconanoparticles could stabilize either the alpha-helix or beta-strand conformation of the third variable region (V3 peptide) of the HIV-1 gp120 [101] . The peptide on the nanoparticles shows more stability toward peptidase degradation compared to the free peptide. V3 beta-glyconanoparticles produce antibodies in rabbits that recognize a recombinant gp120, and the serum showed consistent .....
    Document: It was shown that conjugation to negatively charged gold glyconanoparticles could stabilize either the alpha-helix or beta-strand conformation of the third variable region (V3 peptide) of the HIV-1 gp120 [101] . The peptide on the nanoparticles shows more stability toward peptidase degradation compared to the free peptide. V3 beta-glyconanoparticles produce antibodies in rabbits that recognize a recombinant gp120, and the serum showed consistent neutralizing activity. These results potentially allow for the design of new fully synthetic HIV vaccine candidates [101] .

    Search related documents:
    Co phrase search for related documents
    • alpha helix and beta strand alpha helix: 1, 2, 3, 4
    • alpha helix and beta strand alpha helix conformation: 1
    • alpha helix and peptidase degradation: 1
    • alpha helix and peptidase degradation stability: 1
    • antibody produce and HIV vaccine: 1
    • antibody produce and neutralizing activity: 1
    • beta strand alpha helix and peptidase degradation: 1
    • beta strand alpha helix conformation and peptidase degradation: 1
    • beta strand and peptidase degradation: 1
    • consistent neutralizing activity and free peptide: 1
    • consistent neutralizing activity and neutralizing activity: 1, 2, 3, 4, 5, 6, 7
    • free peptide and neutralizing activity: 1
    • HIV vaccine and neutralizing activity: 1, 2, 3, 4, 5, 6, 7, 8, 9